Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study

Aust N Z J Psychiatry. 2004 Jun;38(6):445-9. doi: 10.1080/j.1440-1614.2004.01382.x.

Abstract

Objective: To determine whether acute neuroleptic-induced parkinsonism and akathisia were risk factors for the later development of tardive dyskinesia (TD) in patients on typical neuroleptics.

Method: Of 100 subjects examined for parkinsonism and akathisia after the initiation of typical neuroleptic medication, 78 were followed up for TD after a mean 41.2 months.

Results: Nine (11.5%) subjects were diagnosed with TD, predominantly manifesting as oro-facial dyskinesia. They had greater severity of parkinsonism and akathisia at baseline, and a larger neuroleptic load, than those who did not develop TD. On regression analyses, parkinsonism at baseline was a significant predictor of later TD. Examined independently of parkinsonism, akathisia severity at 2 weeks was also a significant predictor of later TD.

Conclusions: Acute drug-induced parkinsonism and akathisia are both predictors of TD, with parkinsonism having greater predictive value. Acute and tardive extrapyramidal syndromes may share vulnerability factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Basal Ganglia Diseases / chemically induced*
  • Basal Ganglia Diseases / diagnosis
  • Basal Ganglia Diseases / epidemiology*
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / epidemiology*
  • Dyskinesia, Drug-Induced / etiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Parkinsonian Disorders / drug therapy
  • Predictive Value of Tests
  • Prospective Studies
  • Psychomotor Agitation / drug therapy
  • Risk Factors
  • Severity of Illness Index
  • Time Factors

Substances

  • Antipsychotic Agents